Prolastin-C Liquid 1000 mg/20 ml

Prolastin-C Liquid 1000 mg/20 ml is a medicine authorised by Swissmedic under authorisation number 69448. The authorisation holder is OM Pharma Suisse SA. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 25 November 2024 and the authorisation is limited until 24 November 2029. ATC code B02AB02 places the medicine in the group Antihemorrhagics.

  • Dispensing category B
  • Authorisation number 69448
  • ATC B02AB02
  • Blood products
Authorisation data
Authorisation number69448
NameProlastin-C Liquid 1000 mg/20 ml
Full nameProlastin-C Liquid 1000 mg/20 ml, solution pour perfusion
Authorisation holderOM Pharma Suisse SA
Medicinal product codeBlood products
Dispensing categoryB · Prescription only
ATC codeB02AB02
First authorisation25 November 2024
Authorisation validity24 November 2029
Strengths
No.NameDispensing categoryAuthorisation date
2Prolastin-C Liquid 1000 mg/20 ml, solution pour perfusionB25 November 2024
3Prolastin-C Liquid 4000 mg/80 ml, solution pour perfusionB25 November 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
21x 20 mlDurchstechflasche(n)B02AB0206.01.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Prolastin-C Liquid 1000 mg/20 ml authorised in Switzerland?

Yes. Prolastin-C Liquid 1000 mg/20 ml is authorised by Swissmedic under authorisation number 69448, data as of 01 September 2026. The authorisation is limited until 24 November 2029.

Which dispensing category does Prolastin-C Liquid 1000 mg/20 ml have?

Prolastin-C Liquid 1000 mg/20 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Prolastin-C Liquid 1000 mg/20 ml?

The authorisation holder is OM Pharma Suisse SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com